81 related articles for article (PubMed ID: 29623837)
41. Molecular mechanisms of hexavalent chromium-induced apoptosis in human bronchoalveolar cells.
Russo P; Catassi A; Cesario A; Imperatori A; Rotolo N; Fini M; Granone P; Dominioni L
Am J Respir Cell Mol Biol; 2005 Dec; 33(6):589-600. PubMed ID: 16166740
[TBL] [Abstract][Full Text] [Related]
42. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
43. Microglia-derived IL-1β triggers p53-mediated cell cycle arrest and apoptosis in neural precursor cells.
Guadagno J; Swan P; Shaikh R; Cregan SP
Cell Death Dis; 2015 Jun; 6(6):e1779. PubMed ID: 26043079
[TBL] [Abstract][Full Text] [Related]
44. In vitro binding properties of tumor suppressor p53 with PUMA and NOXA.
Park SY; Jeong MS; Jang SB
Biochem Biophys Res Commun; 2012 Apr; 420(2):350-6. PubMed ID: 22446329
[TBL] [Abstract][Full Text] [Related]
45. β-Arrestin-2 modulates radiation-induced intestinal crypt progenitor/stem cell injury.
Liu Z; Tian H; Jiang J; Yang Y; Tan S; Lin X; Liu H; Wu B
Cell Death Differ; 2016 Sep; 23(9):1529-41. PubMed ID: 27128598
[TBL] [Abstract][Full Text] [Related]
46. Effect of capilliposide for induction apoptosis in human nasopharyngeal cancer CNE-2 cells through up-regulating PUMA expression.
Hua Y; Hu Q; Piao Y; Tang Q; Feng J
J Cancer Res Ther; 2015 Nov; 11 Suppl():C239-43. PubMed ID: 26612445
[TBL] [Abstract][Full Text] [Related]
47. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome.
Qiu W; Carson-Walter EB; Liu H; Epperly M; Greenberger JS; Zambetti GP; Zhang L; Yu J
Cell Stem Cell; 2008 Jun; 2(6):576-83. PubMed ID: 18522850
[TBL] [Abstract][Full Text] [Related]
48. Radioprotective agents to prevent cellular damage due to ionizing radiation.
Smith TA; Kirkpatrick DR; Smith S; Smith TK; Pearson T; Kailasam A; Herrmann KZ; Schubert J; Agrawal DK
J Transl Med; 2017 Nov; 15(1):232. PubMed ID: 29121966
[TBL] [Abstract][Full Text] [Related]
49. A Chemical Modulator of p53 Transactivation that Acts as a Radioprotective Agonist.
Morita A; Takahashi I; Sasatani M; Aoki S; Wang B; Ariyasu S; Tanaka K; Yamaguchi T; Sawa A; Nishi Y; Teraoka T; Ujita S; Kawate Y; Yanagawa C; Tanimoto K; Enomoto A; Nenoi M; Kamiya K; Nagata Y; Hosoi Y; Inaba T
Mol Cancer Ther; 2018 Feb; 17(2):432-442. PubMed ID: 28939557
[TBL] [Abstract][Full Text] [Related]
50. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.
Bonora M; Wieckowski MR; Sinclair DA; Kroemer G; Pinton P; Galluzzi L
Nat Rev Cardiol; 2019 Jan; 16(1):33-55. PubMed ID: 30177752
[TBL] [Abstract][Full Text] [Related]
51. Neuroprotective agents effective against radiation damage of central nervous system.
Lalkovicova M
Neural Regen Res; 2022 Sep; 17(9):1885-1892. PubMed ID: 35142663
[TBL] [Abstract][Full Text] [Related]
52. Abstract 4: Site Specific Targeting of PUMA Induced ROS Prevents Radiation Injury via a Smad3 Independent Mechanism.
Mehta K; Lotfi P; Soares M; Dolitsky R; Rabbani P; Ducksworth A; Rao N; Chang J; Hua A; Doig C; Kim C; Saadeh P; Ceradini D
Plast Reconstr Surg; 2014 Mar; 133(3 Suppl):12. PubMed ID: 25942115
[No Abstract] [Full Text] [Related]
53. The Transplantation of hBM-MSCs Increases Bone Neo-Formation and Preserves Hearing Function in the Treatment of Temporal Bone Defects - on the Experience of Two Month Follow Up.
Školoudík L; Chrobok V; Kočí Z; Popelář J; Syka J; Laco J; Filipová A; Syková E; Filip S
Stem Cell Rev Rep; 2018 Dec; 14(6):860-870. PubMed ID: 29860618
[TBL] [Abstract][Full Text] [Related]
54. Bbc3 Loss Enhances Survival and Protein Clearance in Neurons Exposed to the Organophosphate Pesticide Chlorpyrifos.
Anderson FL; von Herrmann KM; Young AL; Havrda MC
Toxicol Sci; 2021 Sep; 183(2):378-392. PubMed ID: 34289071
[TBL] [Abstract][Full Text] [Related]
55. Hirsutanol A inhibits T-acute lymphocytic leukemia Jurkat cell viability through cell cycle arrest and p53-dependent induction of apoptosis.
Zhong F; Yang Y; Ren D; Long S; Qin X; Liu J; Zeng Y; Lan W; Ma W; Liu W
Exp Ther Med; 2021 Jul; 22(1):741. PubMed ID: 34055057
[TBL] [Abstract][Full Text] [Related]
56. Substituted Piperazines as Novel Potential Radioprotective Agents.
Filipova A; Marek J; Havelek R; Pejchal J; Jelicova M; Cizkova J; Majorosova M; Muckova L; Kucera T; Prchal L; Psotka M; Zivna N; Koutova D; Sinkorova Z; Rezacova M; Tichy A
Molecules; 2020 Jan; 25(3):. PubMed ID: 31991816
[TBL] [Abstract][Full Text] [Related]
57. New Light on An Old Friend: Targeting PUMA in Radioprotection and Therapy of Cardiovascular and Neurodegenerative Diseases.
Tichy A; Marek J; Havelek R; Pejchal J; Seifrtova M; Zarybnicka L; Filipova A; Rezacova M; Sinkorova Z
Curr Drug Targets; 2018; 19(16):1943-1957. PubMed ID: 29623837
[TBL] [Abstract][Full Text] [Related]
58. The role of P53 up-regulated modulator of apoptosis (PUMA) in ovarian development, cardiovascular and neurodegenerative diseases.
Li M
Apoptosis; 2021 Jun; 26(5-6):235-247. PubMed ID: 33783663
[TBL] [Abstract][Full Text] [Related]
59. Development of small-molecule PUMA inhibitors for mitigating radiation-induced cell death.
Mustata G; Li M; Zevola N; Bakan A; Zhang L; Epperly M; Greenberger JS; Yu J; Bahar I
Curr Top Med Chem; 2011; 11(3):281-90. PubMed ID: 21320058
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
